Concepedia

Michael Friedrich

MF

Statistics

Publications

9

Citations

224

H-Index

9

Active since

2010

Affiliations

Martin Luther University Halle-Wittenberg(Current)

University Hospital of Zurich

Friedrich-Alexander-Universität Erlangen-Nürnberg

Helios Klinikum Krefeld

Luther University

Michael Friedrich is an author at Martin Luther University Halle-Wittenberg specializing in oncology, tumor antigens, and immunology.

ORCID

Publications per year

2010–2022

9

Publications

9

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

Maria‐Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa et al. · OncoImmunology · 2020 · 41 citations · Full text

, , +17

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma

Sandy Tretbar, Peter Krausbeck, Anja Müller et al. · Oncotarget · 2019 · 37 citations · Full text

, , +15

Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744

Michael Friedrich, Christoforos Vaxevanis, Katharina Biehl et al. · Journal for ImmunoTherapy of Cancer · 2020 · 32 citations · Full text

, , +17

CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma

Michael Friedrich, Nadine Heimer, André Steven et al. · Scientific Reports · 2020 · 31 citations · Full text

, , +17

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma

Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke et al. · Journal of Clinical Medicine · 2020 · 26 citations · Full text

, , +17

1–5 of 9